Print

Clinical Payment and Coding Policies

This information does not apply to members who have Medicaid or Medicare plans.

Clinical payment and coding policies are based on criteria developed by specialized professional societies, national guidelines (e.g. Milliman Care Guidelines (MCG)) and the CMS Provider Reimbursement Manual. Additional sources are used and can be provided upon request. The clinical payment and coding guidelines are not intended to provide billing or coding advice but to serve as a reference for facilities and providers. 

Certain policies may not be applicable to Self-Funded Members and certain insured products. Refer to the Member's plan of benefits or Certificate of Coverage to determine whether coverage is provided or if there are any exclusions or benefit limitations applicable to any of these policies. If there is a difference between any policy and the Member’s plan of benefits or Certificate of Coverage, the plan of benefits or Certificate of Coverage will govern. 

In the event of conflict between a Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern. Plan documents include, but are not limited to, Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents. 

In the event of conflict between a Clinical Payment and Coding Policy and any provider contract pursuant to which a provider participates in and/or provides services to eligible member(s) and/or plans, the provider contract will govern. 

View the current policies below:

Policy Name Policy Number & VersionEffective Date

Anesthesia Clinical Payment and Coding Information 

CPCP010 v.3.0  9/13/2021

Applied Behavior Analysis 

CPCP011 v.2.0  11/9/2021

Chiropractic Services 

CPCP016 v.1.0  1/1/2022
Coordinated Home Care/Private Duty Nursing CPCP05 v.1.0  10/08/2021
Corrected Claim Submissions CPCP25 v.2.0  5/1/2020

Co-Surgeon/Team Surgeon Modifiers 

CPCP009 v.1.0  10/5/2021

Drug Testing Clinical Payment and Coding Policy

CPCP20 v.3.0  12/29/2021
Evaluation and Management (E/M) Services Coding – Facility Services   CPCP003 v.1.0  12/1/2021
Evaluation and Management (E/M) Coding – Professional Provider Services CPCP024 v.3.0  12/23/2021

Global Surgical Package 

CPCP014 v.1.0  5/11/2021

Hernia Repair 

CPCP012 v.2.0  6/18/2021

Home Infusion

CPCP019 v.3.0  9/7/2021

Implant Payment and Coding Policy 

CPCP007 v.1.0  7/6/2020

Increased Procedural Services (Modifier 22) 

CPCP013 v.2.0  5/1/2021
Inpatient Readmissions  CPCP027 v.2.0  12/1/2021
Inpatient/Outpatient Unbundling Policy  CPCP002 v.1.0  12/16/2021
Intraoperative Neurophysiology Monitoring Coding and Reimbursement Guideline  CPCP032 v.3.0  7/30/2021

Laboratory Panel Billing Guideline

CPCP021 v.2.0  7/30/2021

Medical Record Documentation Guidelines 

CPCP029 v.5.0  9/22/2021

Modifier Reference Guideline 

CPCP023 v.2.0  4/1/2021

Multiple Surgical Procedures 

CPCP015 v.1.0  8/24/2021

Neonatal Intensive Care Unit (NICU) Level of Care Authorization and Reimbursement Policy

CPCP004 v.2.0

 12/13/2021

Non-Reimbursable Experimental, Investigational and/or Unproven Services (EIU)

CPCP028 v.2.0  8/15/2021

Non-Reimbursable Experimental, Investigational and/or Unproven Services (EIU)

CPCP028 v.3.0  4/1/2022
Observation Services Tool for Applying MCG Care Guidelines Clinical Payment and Coding Policy  CPCP001 v.2.0  7/20/2021

Outpatient Facility and Hospital Claims: Revenue Codes Requiring CPT or HCPCS Codes

CPCP018 v.1.0  12/1/2021

Paravertebral Facet Injection Procedure Coding & Billing Policy  

CPCP036 v.8.0  11/2/2021

Pneumatic Compression Devices 

CPCP022 v.1.0  12/10/2021

Point-of-Care Ultrasound Examination Guideline

CPCP030 v.1.0  6/4/2021

Preventive Services Policy 

CPCP006 v.1.0  1/1/2022

Psychological and Neuropsychological Testing

CPCP008 v.1.0  4/1/2021

Trauma Activation - Facility Services 

CPCP031 v.1.0  5/11/2021

Unbundling Professional 

CPCP034 v.2.0  8/4/2021

Wasted/Discarded Drugs and Biologicals Guideline

CPCP017 v.4.0  12/21/2021

 

 

Policy Name Policy Number Effective Date

Allergen Testing 

CPCPLAB013

5/1/2022

ANA/ENA Testing 

CPCPLAB011

5/1/2022

β-Hemolytic Streptococcus Testing 

CPCPLAB053

5/1/2022

Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases  CPCPLAB036

5/1/2022

Cardiac Biomarkers for Myocardial Infarction  CPCPLAB046

5/1/2022

Cardiovascular Disease Risk Assessment 

CPCPLAB020

5/1/2022

Celiac Disease Testing

CPCPLAB017

5/1/2022

Cervical Cancer Screening   CPCPLAB002

5/1/2022

Coronavirus Testing in the Outpatient Setting  CPCPLAB057

5/1/2022

Diagnosis of Idiopathic Environmental Intolerance 

CPCPLAB023

5/1/2022

Diagnosis of Vaginitis including Multi-target PCR Testing 

CPCPLAB059

5/1/2022

Diagnostic Testing of Common Sexually Transmitted Infections 

CPCPLAB051

5/1/2022

Diagnostic Testing of Influenza 

CPCPLAB033

5/1/2022

Diagnostic Testing of Iron Homeostasis & Metabolism 

CPCPLAB008

5/1/2022

DNA Ploidy Cell Cycle Analysis  CPCPLAB066

5/1/2022

Epithelial Cell Cytology in Breast Cancer Risk Assessment  CPCPLAB024

5/1/2022

Erectile Dysfunction  CPCPLAB041

5/1/2022

Evaluation of Dry Eyes   CPCPLAB043

 5/1/2022

Fecal Analysis in the Diagnosis of Intestinal Dysbiosis   CPCPLAB025

 5/1/2022

Fecal Calprotectin Testing   CPCPLAB026

 5/1/2022

Flow Cytometry   CPCPLAB001

 5/1/2022

Folate Testing   CPCPLAB048

 5/1/2022

Gamma-glutamyl Transferase   CPCPLAB056

 5/1/2022

General Inflammation Testing   CPCPLAB049

 5/1/2022

Genetic Testing for Adolescent Idiopathic Scoliosis 

CPCPLAB060 

 5/1/2022

Helicobacter Pylori Testing   CPCPLAB018

 5/1/2022

Hemoglobin A1c  CPCPLAB004

5/1/2022

Hepatitis C  CPCPLAB015

5/1/2022

Identification of Microorganisms using Nucleic Acid Probes   CPCPLAB063

 5/1/2022

Immune Cell Function Assay  CPCPLAB028

 5/1/2022

Immunohistochemistry CPCPLAB069

 5/1/2022

In Vitro Chemoresistance and Chemosensitive Assays CPCPLAB030

 5/1/2022

Intracellular Micronutrient Analysis CPCPLAB029

 5/1/2022

Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease 

CPCPLAB035

5/1/2022

Lyme Disease 

CPCPLAB044

5/1/2022

Measurement of Thromboxane Metabolites for ASA Resistance 

CPCPLAB031

5/1/2022

Molecular Testing for Chronic Heart Failure 

CPCPLAB040

5/1/2022

Nerve Fiber Density Testing 

CPCPLAB064

5/1/2022

Onychomycosis Testing 

CPCPLAB068

5/1/2022

Oral Screening Lesion Identification Systems and Genetic Screening 

CPCPLAB032

5/1/2022

Pancreatic Enzyme Testing for Acute Pancreatitis  CPCPLAB047

5/1/2022

Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing 

CPCPLAB055

5/1/2022

Pathogen Panel Testing 

CPCPLAB045

5/1/2022

Pediatric Preventive Screening 

CPCPLAB016

5/1/2022

Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection

CPCPLAB065

5/1/2022

Prenatal Screening 

CPCPLAB014

5/1/2022

Prenatal Screening for Fetal Aneuploidy 

CPCPLAB022

5/1/2022

Pre-Operative Testing 

CPCPLAB012

5/1/2022

Prescription Medication and Illicit Drug Testing in the Outpatient Setting CPCPLAB070

5/1/2022

Preventive Screening in Adults CPCPLAB007

5/1/2022

Prostate Biopsies CPCPLAB005

5/1/2022

Prostate Specific Antigen Testing CPCPLAB006

5/1/2022

Salivary Hormone Testing CPCPLAB034

5/1/2022

Serum Tumor Markers for Malignancies CPCPLAB037

5/1/2022

Testing for Alpha-1 Antitrypsin Deficiency CPCPLAB061

5/1/2022

Testing for Diagnosis of Active or Latent Tuberculosis CPCPLAB027

5/1/2022

Testing for Mosquito- or Tick-Related Infections CPCPLAB052

5/1/2022

Testing of Homocysteine Metabolism-Related Conditions CPCPLAB067

5/1/2022

Testosterone Testing CPCPLAB009

5/1/2022

Thyroid Disease Testing CPCPLAB019

5/1/2022

Urinary Tumor Markers for Bladder Cancer CPCPLAB038

5/1/2022

Urine Culture Testing for Bacteria CPCPLAB050

5/1/2022

Vectra DA Blood Test for Rheumatoid Arthritis CPCPLAB039

5/1/2022

Venous and Arterial Thrombosis Risk Testing CPCPLAB058

5/1/2022

Vitamin B12 and Methylmalonic Acid Testing CPCPLAB010

5/1/2022

Vitamin D CPCPLAB003

5/1/2022

ZIKA Virus Risk Assessment CPCPLAB042

5/1/2022